Javascript must be enabled to continue!
FRAGILE-X SYNDROME PREMATURE OVARIAN INSUFFICIENCY: IS IT TIME TO REAPPRAISAL ITS SCREENING?
View through CrossRef
AbstractPremature ovarian insufficiency is idiopathic in 90% of cases and fragile x syndrome occurs in 2% of sporadic cases, chiefly in pre mutation carriers. It can be a devastating diagnosis since prevents them of childbearing. Current guidelines recommends pre mutation carrier screening for women with a family history of fragile x syndrome-related disorders, intellectual disability, or unexplained premature ovarian failure, when they consider pregnancy, although several phenotypes exist. This article describes fragile x syndrome ovarian insufficiency with migraine and depression, as well as reappraisal its management. A 35 year-old woman had migraine and regular menses since menarche until premature ovarian insufficiency appeared after oral contraceptive withdrawal, at 33 year-old. The FSH values varied from 10 to 165 mUI/mL. As her father start having ataxia after 55 years-old, she performed molecular study, which showed 94 repeat CGG. However, she could not spontaneous childbearing, because the anti-Müllerian hormone value was 0,16ng/dL. This made her so depressive to the point of seeking psychiatric treatment. This supports a differentiated approach through early pre mutation carrier screening and monitoring of ovarian function, aiming at pregnancy, or the institution of hormone therapy when necessary.
Revista Cientifica da Faculdade de Medicina de Campos
Title: FRAGILE-X SYNDROME PREMATURE OVARIAN INSUFFICIENCY: IS IT TIME TO REAPPRAISAL ITS SCREENING?
Description:
AbstractPremature ovarian insufficiency is idiopathic in 90% of cases and fragile x syndrome occurs in 2% of sporadic cases, chiefly in pre mutation carriers.
It can be a devastating diagnosis since prevents them of childbearing.
Current guidelines recommends pre mutation carrier screening for women with a family history of fragile x syndrome-related disorders, intellectual disability, or unexplained premature ovarian failure, when they consider pregnancy, although several phenotypes exist.
This article describes fragile x syndrome ovarian insufficiency with migraine and depression, as well as reappraisal its management.
A 35 year-old woman had migraine and regular menses since menarche until premature ovarian insufficiency appeared after oral contraceptive withdrawal, at 33 year-old.
The FSH values varied from 10 to 165 mUI/mL.
As her father start having ataxia after 55 years-old, she performed molecular study, which showed 94 repeat CGG.
However, she could not spontaneous childbearing, because the anti-Müllerian hormone value was 0,16ng/dL.
This made her so depressive to the point of seeking psychiatric treatment.
This supports a differentiated approach through early pre mutation carrier screening and monitoring of ovarian function, aiming at pregnancy, or the institution of hormone therapy when necessary.
Related Results
Diagnostic value of shear wave velocity in polycystic ovarian syndrome
Diagnostic value of shear wave velocity in polycystic ovarian syndrome
Aim: In polycystic ovarian syndrome, the ovaries become stiffer due to chronic
anovulation. We aimed to compare tissue elasticity in terms of shear wave velocities
...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
P–688 Assessment of ovarian vascularity by three-dimensional vaginal power Doppler on day two of menstrual cycle to predict the number of mature eggs collected
P–688 Assessment of ovarian vascularity by three-dimensional vaginal power Doppler on day two of menstrual cycle to predict the number of mature eggs collected
Abstract
Study question
Could ovarian vascularity indices, measured by 3-dimensional (3D) vaginal power Doppler, predict the num...
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Abstract
Background
2020 World Health Organization Classification of Female Genital Tumors removed ovarian seromucinous carcinoma as a distinct enti...
P-677 fasting-mimicking diet delays ovarian aging by modulating immune cells and enhancing glycocholic acid levels
P-677 fasting-mimicking diet delays ovarian aging by modulating immune cells and enhancing glycocholic acid levels
Abstract
Study question
Does fasting-mimicking diet (FMD) alleviate ovarian aging in mice, and what roles do gut and serum metab...
Not Just for Tough Times: The Efficacy and Mechanisms of Reappraisal in Negative, Neutral, and Positive Contexts
Not Just for Tough Times: The Efficacy and Mechanisms of Reappraisal in Negative, Neutral, and Positive Contexts
Reappraisal is a common emotion regulation strategy that involves adjusting how a situation is appraised. While much is known about its use to reduce negative affect in negative si...
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract
Epithelial ovarian cancer (EOC) accounts for 5% of all cancer deaths and is the fifth leading cause of cancer death in women in the United States. While the...
The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ
The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ
Abstract
The female upper reproductive tract, including the uterus, fallopian tubes and ovaries, is believed to be a sterile environment. With the improvement of ba...

